# Linzhi Jianghuang Fufang Huoxue Anshen Capsule for Non-alcoholic Fatty Liver

> **NCT07637006** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Hong Kong Baptist University** · enrollment: 180 (estimated)

## Conditions studied

- Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)

## Interventions

- **DRUG:** Linzhi Jianghuang Fufang Huoxue Anshen Capsule (LJF)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07637006
- **Lead sponsor:** Hong Kong Baptist University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-07
- **Final completion:** 2029-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07637006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07637006, "Linzhi Jianghuang Fufang Huoxue Anshen Capsule for Non-alcoholic Fatty Liver". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07637006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*